Arrowhead Pharmaceuticals (ARWR) Asset Utilization Ratio (2011 - 2026)

Arrowhead Pharmaceuticals' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.32 for Q1 2026.

• Quarterly Asset Utilization Ratio fell 23.78% year-over-year to 0.32 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.32 (down 23.78% YoY) and the FY2025 annual result came in at 0.66, up 17525.28% from the prior year.
• Asset Utilization Ratio was 0.32 for Q1 2026 at Arrowhead Pharmaceuticals, down from 0.73 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.73 in Q4 2025 and bottomed at 0.0 in Q4 2024.
• A 5-year average of 0.3 and a median of 0.32 in 2026 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2024 — Asset Utilization Ratio plunged 99.11% — and 2025, when it soared 31335.92%.
• Arrowhead Pharmaceuticals' Asset Utilization Ratio stood at 0.35 in 2022, then slipped by 25.72% to 0.26 in 2023, then plunged by 99.11% to 0.0 in 2024, then soared by 31335.92% to 0.73 in 2025, then tumbled by 55.99% to 0.32 in 2026.
• Business Quant data shows ARWR's Asset Utilization Ratio at 0.32 in Q1 2026, 0.73 in Q4 2025, and 0.6 in Q3 2025.